AUT Professor Wins Supreme Innovator Award
MEDIA RELEASE
22 October, 2015
AUT Professor Wins Supreme Innovator Award for Potential Cancer Treatment
An AUT Professor whose work could forever change the way cancer is treated was named Supreme Innovator at the New Zealand Innovators Awards last night.
Steve Henry is the CEO of KODE Biotech Ltd and Professor of Biotech Innovation at Auckland University of Technology. Professor Henry’s most high profile work has been developing a “coating” for a UK company that has developed a novel cancer therapy. The coating changes the appearance of cancer cells, making them take on the appearance of an animal cell, which the immune system already knows how to reject.
Professor Henry signed a deal with the UK based Agalimmune in March, which will see Kode™ Technology injected into cancer tumours. It begins working immediately after injection into a single tumour and within a few weeks will have taught the immune system how to identify and attack cancer elsewhere in the body. The treatment is expected to have such low toxicity that the side effects would be no worse than the flu jab. Human clinical trials are expected to begin in Europe next year.
At the awards ceremony in Auckland last night, Kode Biotech won Best Innovation in Health and Science, and Professor Henry won Supreme Innovator of the year.
“Winning these awards means a lot to me, particularly as it is a recognition of the hard work done over many years by my team, and of the support Kode Biotech has received from AUT and our investors,” says Professor Henry.
The head of AUT’s School of Engineering, Professor Enrico Haemmerle, says it was great to see Steve praised in this way.
“Steve Henry is an inventor, but more importantly, an innovator who has the ability to convert ideas into commercial value. He is an ongoing inspiration to AUT students and staff, and it is great to see his important work getting the recognition it deserves. “
Notes:
Agalimmune is pronounced Aye-GAL-a-mune
Enrico Haemmerle’s surname is pronounced HAM-a-la